| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10318331 | Research in Developmental Disabilities | 2010 | 7 Pages |
Abstract
Antipsychotic drugs are the most frequently prescribed of the psychotropic drugs among the intellectually disabled (ID) population. Given their widespread use, efforts to systematically assess and report side effects are warranted. Specific scaling methods such as the Matson Evaluation of Side Effects (MEDS), the Abnormal Inventory Movement Scale (AIMS), and Dyskinesia Identification System Condensed User Scale (DISCUS) are reviewed. Symptom patterns and a focus on additional research are discussed. While progress has been made, more and more systematic methods to research these problems are necessary.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Johnny L. Matson, Sara Mahan,